China: Chinese healthcare companies turn to US for funding

Chinese healthcare companies are increasingly turning to the US markets for their initial public offerings with three currently planning IPOs before the end of the year. Joining cancer-screening diagnostics company Anpac Bio-Medical, which announced plans to raise US$27m on Nasdaq in mid-November, two other companies have made their intentions clear over the past week. Cancer…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »